CRDF
Cardiff Oncology Inc
1.30$
-1.5%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2005 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +72.7% | -83.2% | +22.6% | +267.9% | +244.9% | +79.9% | +61.3% | +182.5% | +16.6% | -31.2% | -42.5% | -5.7% | -3.2% | -47.7% | +68.6% | +1.5% | +123.8% | |
| – | – | – | -23.0% | +112.0% | +272.0% | +4.6% | +90.6% | +90.2% | -46.5% | -45.8% | -59.3% | +99.4% | +83.2% | +31.6% | +5.9% | +5.6% | +19.6% | |
| – | – | – | – | – | – | -79.9% | +655.0% | +20.2% | -40.9% | -37.0% | -59.0% | +142.8% | +41.8% | +44.3% | – | – | – | |
| – | -1,403.3% | – | +1,161.6% | -235.1% | – | -59.4% | -131.5% | – | -387.3% | – | +1,014.3% | -159.9% | – | – | – | -51.7% | -31.3% | |
| – | – | +177.5% | -94.5% | +17,575.4% | +140.4% | -44.0% | +516.9% | -63.3% | -87.8% | -94.9% | +1,233.3% | +211.6% | -3.2% | +335.1% | -34.8% | -86.3% | -45.0% | |
| – | -86.3% | +1,224.5% | -98.8% | +17,575.4% | +140.4% | -53.8% | +645.0% | +1,011.9% | – | -99.9% | -394.0% | +213.3% | +61,938.9% | – | -5.1% | -62.1% | -90.2% | |
| – | – | – | – | – | – | – | +5.3% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | -99.9% | +1,625.0% | – | – | – | |
| – | – | – | – | – | – | – | – | -61.8% | +3.6% | +27.8% | -62.2% | +100.0% | +46.2% | -99.8% | – | – | – | |
| – | – | – | – | – | – | +2,707.2% | -92.5% | -132.3% | +4,811.4% | -92.0% | – | – | – | – | – | – | – | |
| – | -67.7% | +5.1% | +48.4% | +495.5% | +50.0% | -37.0% | +345.7% | -96.4% | -377.1% | – | -26.4% | +1,036.9% | -74.2% | -99.8% | -100.0% | – | -95.2% | |
| – | -35.7% | -218.6% | – | +1,477.0% | +48.4% | -90.3% | +2,659.3% | -233.3% | – | – | -139.0% | – | -198.6% | – | +20.5% | +461.7% | -214.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.